You are here

Danielle Blake
October 20, 2014

Rep. Scott Peters, California CEOs Hold Roundtable to Address Building Healthier Economies, Delivering MedTech Value to Patients

U.S. Rep. Scott Peters (D-CA) joined CEOs from California’s medical device companies in a robust roundtable discussion today to address how the sector can help build and drive a healthy local economy while delivering value to patients worldwide. The roundtable took place at CareFusion headquarters in San Diego.

California is the nation’s leading state for medical technology, employing more than 295,000 people. In total, the state contributes nearly $59 billion dollars to the economy, making it one of California’s most thriving employment sectors. Overall, the industry supports more than two million jobs across the country.

Participants in the roundtable noted that sustaining this positive impact requires the right public policies to support value creation and continued investment in research and development – the kind of investment that helps grow high-technology manufacturing jobs in America.

“It is critical that our state and federal legislators recognize the significant economic contributions made by medical device companies in California, so they can continue to advocate for policies that allow our industry to grow and lead the world in medical innovation,” said Kieran Gallahue, chairman and CEO of CareFusion. “We are proud that our industry can make powerful contributions to the state of California and across the U.S., and we look forward to creating even more growth and innovation to further improve the business environment.”

“With San Diego leading the way in this field, I’m always glad to hear from local innovation leaders on how I can showcase our region’s collaborative approach to the rest of the country,” said Rep. Scott Peters (CA-52). “I have been a vocal advocate for the immense potential of medical technology to power our local economy and help bend the cost curve of healthcare, which is why I voted to repeal the medical device tax and introduced two health IT focused bills this year.”

Advanced medical technologies help patients live longer, healthier lives and get them back to work more quickly while lowering long-term health care costs. Over the last 30 years, medical progress helped add more than five years to U.S. life expectancy, reducing fatalities from heart disease and stroke by more than half while cutting mortality from breast cancer by over 30 percent.

“We are pleased to have Rep. Peters’ leadership in this very important discussion. The medical technology industry provides incredible value to patients, health care systems and economies, and we are grateful for the opportunity to highlight and identify important policy initiatives that are pivotal for the advancement of the med tech industry in California and throughout the U.S.,” said Duane Wright, vice president of government affairs, Advanced Medical Technology Association (AdvaMed).

“Rep. Peters has been a strong and consistent supporter in our effort to repeal the job-killing $30 billion medical device tax,” Wright continued. “Repealing this tax will help promote growth, job creation and economic competitiveness in California and across the country.”

Other participants in the panel included John Kilcoyne, CEO and president ReVision Optics; Michael Mogul, president, CEO and director DJO Global; and Keith Valentine, president and chief operating officer, NuVasive, Inc.

Learn more about AdvaMed and its Life Changing Innovation campaign, visit

About AdvaMed:

AdvaMed member companies produce the medical devices, diagnostic products and health information systems that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments. AdvaMed members range from the largest to the smallest medical technology innovators and companies. For more information, visit

AdvaMed’s Life Changing Innovation campaign focuses on how medical technology brings value to patients, improved quality and efficiency for health systems, and good-paying jobs and other economic benefits. Learn more and read our industry’s inspiring stories at

About CareFusion 

CareFusion (NYSE: CFN) is a global corporation serving the health care industry with products and services that help hospitals measurably improve the safety and quality of care. The company develops industry-leading technologies including Alaris® infusion pumps and IV sets, MaxPlus® and MaxZero IV connectors and sets, Pyxis® automated dispensing and patient identification systems, AVEA®, LTV® series and AirLife® ventilation and respiratory products, ChloraPrep® products, MedMined® services for data mining surveillance, V. Mueller® surgical instruments, and an extensive line of products that support interventional medicine. CareFusion employs more than 16,000 people across its global operations. More information may be found at